Interim

Enpro to Present at Sidoti Fall 2021 Virtual Conference

Thursday, September 16, 2021 - 3:00pm

EnPro Industries, Inc. (NYSE: NPO) will present at Sidotis Fall 2021 Virtual Conference on Thursday, September 23.

Key Points: 
  • EnPro Industries, Inc. (NYSE: NPO) will present at Sidotis Fall 2021 Virtual Conference on Thursday, September 23.
  • The companys presentation is scheduled for 11:30 a.m. Eastern Time and will be made by Eric Vaillancourt, Interim President and Chief Executive Officer, and James Gentile, Vice President, Investor Relations.
  • Enpro is an industrial technology company focused on niche applications across many end-markets including semiconductor, general industrial, aerospace, food and pharma and life sciences.
  • For more information about Enpro, visit the companys website at http://www.enproindustries.com .

Nabis Holdings Announces Receipt of Interim Order for Plan of Arrangement of Noteholders and Mailing of Meeting Materials

Thursday, September 16, 2021 - 3:30am

Caravel CAD Fund Ltd. (Caravel) opposed the grant of theInterim Order, and in particular, the date proposed to be set for the Noteholders Meeting.

Key Points: 
  • Caravel CAD Fund Ltd. (Caravel) opposed the grant of theInterim Order, and in particular, the date proposed to be set for the Noteholders Meeting.
  • The Company further announces that it has filed and mailed its management information circular (the Information Circular) and related meeting and proxy materials (collectively, the Meeting Materials) for the Noteholder Meeting today.
  • The Company has also commenced the mailing of the notices and management information circular (the Circular) with respect to the Noteholders Meeting.
  • The Board of Directors unanimously recommends that all Noteholders vote in favour of the Plan of Arrangement.

Globee® Awards Announces Winners in the 9th Annual 2021 CEO World Awards®

Wednesday, September 15, 2021 - 4:30pm

SAN FRANCISCO, Sept. 15, 2021 /PRNewswire-PRWeb/ -- The Globee Awards organizer of the world's premier business awards programs and business ranking lists has announced the Grand, Gold, Silver, and Bronze winners in the 9th Annual 2021 CEO World Awards.

Key Points: 
  • SAN FRANCISCO, Sept. 15, 2021 /PRNewswire-PRWeb/ -- The Globee Awards organizer of the world's premier business awards programs and business ranking lists has announced the Grand, Gold, Silver, and Bronze winners in the 9th Annual 2021 CEO World Awards.
  • Winners of Grand GLOBEE CEO World Awards include Best Version Media, NewAge, Inc., P. F. Chang's, Piano, and Tek Leaders Inc.
  • The Annual CEO World Awards is part of the Globee Awards recognition program.
  • For a complete list of the 2021 CEO World Award winners announced, visit https://globeeawards.com/ceo-world-awards/winners/
    Stay posted and read success stories of organizations by subscribing to the Globee Newsletter: https://globeeawards.com/subscribe/
    Globee Awards are conferred in eleven programs and competition: the American Best in Business Awards, Business Excellence Awards (Best Employers), CEO World Awards, Communications Excellence Awards, Cyber Security Global Excellence Awards, Disruptor Company Awards, Golden Bridge Awards, International Best in Business Awards, IT World Awards, Sales, Marketing, & Service Excellence Awards, and Women World Awards.

The Cost of Colic Due to CMA Just Went Down: Perrigo Nutrition Introduces First and Only U.S. Store Brand Hypoallergenic Infant Formula

Wednesday, September 15, 2021 - 3:44pm

Perrigo Nutrition, maker of all Store Brand Infant Formula, has introduced a U.S. Store Brand Hypoallergenic Infant Formula that compares to the nutrition of name-brand hypoallergenic formulas Nutramigenand Similac Alimentum.1

Key Points: 
  • Perrigo Nutrition, maker of all Store Brand Infant Formula, has introduced a U.S. Store Brand Hypoallergenic Infant Formula that compares to the nutrition of name-brand hypoallergenic formulas Nutramigenand Similac Alimentum.1
    Now, for the first time, parents can choose a store brand formula that is clinically tested to manage cow's milk allergies (CMA) and helps babies avoid colic due to CMA.2The new formula is the first and only store brand (generic) extensively hydrolyzed infant formula that meets the American Academy of Pediatrics (AAP) Committee on Nutrition's guidelines for hypoallergenic formulas.
  • More than half of those moms (52 percent) would have also purchased a lower-cost generic store brand hypoallergenic infant formula option if it were available.
  • Our new Store Brand Hypoallergenic Infant Formula gives families a more affordable option in a category where there has been little choice.
  • Perrigo Nutrition, makers of all Store Brand Infant Formula, helps make lives better by providing quality, affordable self-care products.

AKHAN Semiconductor Appoints Tom Lacey Interim CEO

Wednesday, September 15, 2021 - 3:00pm

AKHAN Semiconductor (AKHAN/the Company), a technology company specializing in the fabrication and application of synthetic, lab-grown electronics-grade diamond materials addressing consumer industries and glass coatings, announced today that prolific technology executive Tom Lacey has added Interim CEO to his role as the Companys Board Chairman.

Key Points: 
  • AKHAN Semiconductor (AKHAN/the Company), a technology company specializing in the fabrication and application of synthetic, lab-grown electronics-grade diamond materials addressing consumer industries and glass coatings, announced today that prolific technology executive Tom Lacey has added Interim CEO to his role as the Companys Board Chairman.
  • A four-time public company CEO, Lacey has more than three decades of experience leading both public and private companies in the licensing and technology industries.
  • AKHAN is at an exciting moment in time; amidst a capital raise with a number of well-respected investors while mapping a customer-centric growth strategy, Lacey explained.
  • Weve done an outstanding job taking our Miraj Diamond technology from concept to prototype, and now is the time for massive scale, said Adam Khan, Founder AKHAN Semiconductor.

YouthCare Names Colleen Echohawk as Interim CEO

Wednesday, September 15, 2021 - 2:00pm

SEATTLE, Sept. 15, 2021 /PRNewswire/ --Today, YouthCare ,the Seattle-based nonprofit focused on ending youth homelessness, announcesits engagement of Colleen Echohawk as Interim Chief Executive Officer (CEO).

Key Points: 
  • SEATTLE, Sept. 15, 2021 /PRNewswire/ --Today, YouthCare ,the Seattle-based nonprofit focused on ending youth homelessness, announcesits engagement of Colleen Echohawk as Interim Chief Executive Officer (CEO).
  • Echohawkenters the role witha longstanding reputationfor herhomeless advocacywork, specifically among Native American and Alaska Native people.
  • "Colleen'sleadership andadvocacy on behalf of those experiencing homelessness directly aligns withYouthCare'smission," said Karen Jones, Chair ofYouthCare's Board of Directors.
  • "We are thrilled to have her experience, vision, and collaborative approach leading our agency during a time of great interest in solvingyouth homelessness."

SOC Telemed Announces Departure of CFO, Chris Knibb

Wednesday, September 15, 2021 - 1:30pm

RESTON, Va., Sept. 15, 2021 /PRNewswire/ --SOC Telemed, Inc. (NASDAQ: TLMD, "SOC"), the largest national provider of acute care telemedicine, today announced that Chris Knibb, Chief Financial Officer (CFO), has resigned to pursue other opportunities effective September 23, 2021.

Key Points: 
  • RESTON, Va., Sept. 15, 2021 /PRNewswire/ --SOC Telemed, Inc. (NASDAQ: TLMD, "SOC"), the largest national provider of acute care telemedicine, today announced that Chris Knibb, Chief Financial Officer (CFO), has resigned to pursue other opportunities effective September 23, 2021.
  • "I appreciate Chris' leadership and impact on the SOC team," said Dr. Chris Gallagher, Chief Executive Officer of SOC Telemed.
  • David Fletcher will serve as the Interim Chief Financial Officer of SOC Telemed.
  • SOC Telemed assumes no obligation, and does not intend, to update these forward-looking statements as a result of future events or developments, except as required by law.

Biophytis Announces DMC Second Interim Analysis Efficacy Results in the Promising Zone Allowing Continuation of Phase 2/3 COVA Study With Sarconeos (BIO101) in COVID-19

Wednesday, September 15, 2021 - 7:00am

Dr Muriel Lins, COVA trial coordinator in Belgium declared: with the emergence of the delta variant in Europe, we are happy that this second interim analysis leads to continuation of the COVA study.

Key Points: 
  • Dr Muriel Lins, COVA trial coordinator in Belgium declared: with the emergence of the delta variant in Europe, we are happy that this second interim analysis leads to continuation of the COVA study.
  • Stanislas Veillet, CEO of Biophytis declared: We are thrilled with the DMC recommendation following the second Interim Analysis to continue the COVA study unmodified.
  • The DMC recommendation suggests that the trial is well on track to lead to conclusive efficacy results at final analysis.
  • Interim analysis 2 results shows that the study is currently in the promising zone, therefore the sample size remains unmodified per the current protocol i.e.

Nordic Nanovector Appoints Experienced Pharmaceutical Business Leader Erik Skullerud as Chief Executive Officer

Tuesday, September 14, 2021 - 6:03pm

OSLO, Norway, Sept. 14, 2021 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces the appointment of Erik Skullerud as Chief Executive Officer (CEO).

Key Points: 
  • OSLO, Norway, Sept. 14, 2021 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces the appointment of Erik Skullerud as Chief Executive Officer (CEO).
  • Prior to establishing Element Consulting, Mr Skullerud spent 25 years in the biopharma industry with increasing responsibility in global sales and marketing management roles.
  • Jan H. Egberts, Chairman of Nordic Nanovector's Board of Directors, said: "I am very pleased that Erik has agreed to join Nordic Nanovector.
  • Mr Skullerud added: "I am very much looking forward to this new role at Nordic Nanovector.

Nordic Nanovector Appoints Experienced Pharmaceutical Business Leader Erik Skullerud as Chief Executive Officer

Tuesday, September 14, 2021 - 6:00pm

OSLO, Norway, Sept. 14, 2021 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces the appointment of Erik Skullerud as Chief Executive Officer (CEO).

Key Points: 
  • OSLO, Norway, Sept. 14, 2021 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces the appointment of Erik Skullerud as Chief Executive Officer (CEO).
  • Prior to establishing Element Consulting, Mr Skullerud spent 25 years in the biopharma industry with increasing responsibility in global sales and marketing management roles.
  • Jan H. Egberts, Chairman of Nordic Nanovector's Board of Directors, said: "I am very pleased that Erik has agreed to join Nordic Nanovector.
  • Mr Skullerud added: "I am very much looking forward to this new role at Nordic Nanovector.